Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Proposal and Validation of a Simple Grading Scale (TRANSSPHER Grade) for Predicting Gross Total Resection of Nonfunctioning Pituitary Macroadenomas After Transsphenoidal Surgery.

Mooney MA, Sarris CE, Zhou JJ, Barkhoudarian G, Chicoine MR, Fernandez-Miranda JC, Gardner PA, Hardesty DA, Jahnke H, Kelly DF, Liebelt BD, Mayberg MR, Prevedello DM, Sfondouris J, Sheehy JP, Chandler JP, Yuen KCJ, White WL, Little AS; TRANSSPHER Study Group.

Oper Neurosurg (Hagerstown). 2019 Jan 11. doi: 10.1093/ons/opy401. [Epub ahead of print]

PMID:
30649445
2.
3.

Common risk difference test and interval estimation of risk difference for stratified bilateral correlated data.

Shen X, Ma CX, Yuen KC, Tian GL.

Stat Methods Med Res. 2018 Jan 1:962280218781988. doi: 10.1177/0962280218781988. [Epub ahead of print]

PMID:
29916335
4.

Macimorelin as a Diagnostic Test for Adult GH Deficiency.

Garcia JM, Biller BMK, Korbonits M, Popovic V, Luger A, Strasburger CJ, Chanson P, Medic-Stojanoska M, Schopohl J, Zakrzewska A, Pekic S, Bolanowski M, Swerdloff R, Wang C, Blevins T, Marcelli M, Ammer N, Sachse R, Yuen KCJ.

J Clin Endocrinol Metab. 2018 Aug 1;103(8):3083-3093. doi: 10.1210/jc.2018-00665.

PMID:
29860473
5.

A new multivariate zero-adjusted Poisson model with applications to biomedicine.

Liu Y, Tian GL, Tang ML, Yuen KC.

Biom J. 2018 May 25. doi: 10.1002/bimj.201700144. [Epub ahead of print]

PMID:
29799138
6.

The current state of long-acting growth hormone preparations for growth hormone therapy.

Yuen KCJ, Miller BS, Biller BMK.

Curr Opin Endocrinol Diabetes Obes. 2018 Aug;25(4):267-273. doi: 10.1097/MED.0000000000000416.

PMID:
29746309
7.

Pasireotide treatment does not modify hyperglycemic and corticosterone acute restraint stress responses in rats.

Ribeiro-Oliveira A Jr, Schweizer JROL, Amaral PHS, Bizzi MF, Silveira WCD, Espirito-Santo DTA, Zille G, Soares BS, Schmid HA, Yuen KCJ.

Stress. 2018 Jul;21(4):370-375. doi: 10.1080/10253890.2018.1451838. Epub 2018 Apr 17.

PMID:
29661114
8.

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults.

Johannsson G, Bidlingmaier M, Biller BMK, Boguszewski M, Casanueva FF, Chanson P, Clayton PE, Choong CS, Clemmons D, Dattani M, Frystyk J, Ho K, Hoffman AR, Horikawa R, Juul A, Kopchick JJ, Luo X, Neggers S, Netchine I, Olsson DS, Radovick S, Rosenfeld R, Ross RJ, Schilbach K, Solberg P, Strasburger C, Trainer P, Yuen KCJ, Wickstrom K, Jorgensen JOL; Growth Hormone Research Society.

Endocr Connect. 2018 Mar;7(3):R126-R134. doi: 10.1530/EC-18-0047. Epub 2018 Feb 26. Review.

9.

Taking cohesin and condensin in context.

Yuen KC, Gerton JL.

PLoS Genet. 2018 Jan 25;14(1):e1007118. doi: 10.1371/journal.pgen.1007118. eCollection 2018 Jan. Review.

10.

Evaluation of Evidence of Adrenal Insufficiency in Trials of Normocortisolemic Patients Treated With Mifepristone.

Yuen KCJ, Moraitis A, Nguyen D.

J Endocr Soc. 2017 Feb 21;1(4):237-246. doi: 10.1210/js.2016-1097. eCollection 2017 Apr 1.

11.

A case series of atypical features of patients with biopsy-proven isolated IgG4-related hypophysitis and normal serum IgG4 levels.

Yuen KCJ, Moloney KJ, Mercado JU, Rostad S, McCullough BJ, Litvack ZN, Delashaw JB, Mayberg MR.

Pituitary. 2018 Jun;21(3):238-246. doi: 10.1007/s11102-017-0852-4.

PMID:
29248982
12.

Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone Replacement.

Yuen KCJ, Mattsson AF, Burman P, Erfurth EM, Camacho-Hubner C, Fox JL, Verhelst J, Geffner ME, Abs R.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):768-777. doi: 10.1210/jc.2017-01542.

PMID:
29029108
13.

Condensin II is anchored by TFIIIC and H3K4me3 in the mammalian genome and supports the expression of active dense gene clusters.

Yuen KC, Slaughter BD, Gerton JL.

Sci Adv. 2017 Jun 21;3(6):e1700191. doi: 10.1126/sciadv.1700191. eCollection 2017 Jun.

14.

Growth hormone Stimulation Tests in Assessing Adult Growth Hormone Deficiency.

Yuen KCJ.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2016 Aug 1.

16.

Phenotypic characteristics of adolescents with concave and convex facial profiles - The National Health Examination Survey.

Hujoel PP, Bollen AM, Yuen KC, Hujoel IA.

Homo. 2016 Oct;67(5):417-432. doi: 10.1016/j.jchb.2016.04.003. Epub 2016 Apr 18.

PMID:
27129623
17.

Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study.

Hamrahian AH, Yuen KC, Gordon MB, Pulaski-Liebert KJ, Bena J, Biller BM.

Pituitary. 2016 Jun;19(3):332-41. doi: 10.1007/s11102-016-0712-7.

PMID:
26897383
18.

Considering GH replacement for GH-deficient adults with a previous history of cancer: a conundrum for the clinician.

Yuen KC, Heaney AP, Popovic V.

Endocrine. 2016 May;52(2):194-205. doi: 10.1007/s12020-015-0840-2. Epub 2016 Jan 5. Review.

PMID:
26732039
19.

NIPBL Controls RNA Biogenesis to Prevent Activation of the Stress Kinase PKR.

Yuen KC, Xu B, Krantz ID, Gerton JL.

Cell Rep. 2016 Jan 5;14(1):93-102. doi: 10.1016/j.celrep.2015.12.012. Epub 2015 Dec 24.

20.
21.

Convexity of Ruin Probability and Optimal Dividend Strategies for a General Lévy Process.

Yin C, Yuen KC, Shen Y.

ScientificWorldJournal. 2015;2015:354129. doi: 10.1155/2015/354129. Epub 2015 Aug 13.

22.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: A NEUROENDOCRINE APPROACH TO PATIENTS WITH TRAUMATIC BRAIN INJURY.

Tritos NA, Yuen KC, Kelly DF; AACE Neuroendocrine and Pituitary Scientific Committee.

Endocr Pract. 2015 Jul;21(7):823-31. doi: 10.4158/EP14567.DSCR. Review.

PMID:
26172127
23.

ASSOCIATION BETWEEN MIFEPRISTONE DOSE, EFFICACY, AND TOLERABILITY IN PATIENTS WITH CUSHING SYNDROME.

Yuen KC, Williams G, Kushner H, Nguyen D.

Endocr Pract. 2015 Oct;21(10):1087-92. doi: 10.4158/EP15760.OR. Epub 2015 Jun 29. Erratum in: Endocr Pract. 2015 Dec;21(12):1449.

PMID:
26121447
24.

Fixed ratio dosing of pramlintide with regular insulin before a standard meal in patients with type 1 diabetes.

Riddle MC, Yuen KC, de Bruin TW, Herrmann K, Xu J, Öhman P, Kolterman OG.

Diabetes Obes Metab. 2015 Sep;17(9):904-7. doi: 10.1111/dom.12504. Epub 2015 Jul 8.

25.

Growth hormone replacement in patients with a history of malignancy: a review of the literature and best practice for offering treatment.

Yuen KC, Popovic V.

Expert Rev Endocrinol Metab. 2015 May;10(3):319-326. doi: 10.1586/17446651.2015.996130. Epub 2015 Jan 2.

PMID:
30298774
26.

Evaluation of adult growth hormone deficiency: current and future perspectives.

Yuen KCJ, Chong LE, Rhoads SA.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2013 Feb 28.

27.

Mef2c-F10N enhancer driven β-galactosidase (LacZ) and Cre recombinase mice facilitate analyses of gene function and lineage fate in neural crest cells.

Aoto K, Sandell LL, Butler Tjaden NE, Yuen KC, Watt KE, Black BL, Durnin M, Trainor PA.

Dev Biol. 2015 Jun 1;402(1):3-16. doi: 10.1016/j.ydbio.2015.02.022. Epub 2015 Mar 17.

28.

Effects of opioids on the endocrine system: should we be concerned?

Yuen KC.

Endocr Pract. 2015 Apr;21(4):450-1. doi: 10.4158/EP14584.CO. Epub 2015 Feb 25. No abstract available.

PMID:
25716638
29.

Long-term efficacy and safety of pegvisomant therapy in acromegaly.

Yuen KC, Katznelson L.

Endocr Pract. 2015 Mar;21(3):296-8. doi: 10.4158/EP14566.CO. No abstract available.

PMID:
25667381
30.

Overweight/Obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency.

Dichtel LE, Yuen KC, Bredella MA, Gerweck AV, Russell BM, Riccio AD, Gurel MH, Sluss PM, Biller BM, Miller KK.

J Clin Endocrinol Metab. 2014 Dec;99(12):4712-9. doi: 10.1210/jc.2014-2830.

31.

Validation of the Paediatric Hearing Impairment Caregiver Experience (PHICE) Questionnaire.

Lim LH, Xiang L, Wong NL, Yuen KC, Li R.

Ann Acad Med Singapore. 2014 Jul;43(7):362-70.

32.

AACE/ACE Disease State Clinical Review: Medical Management of Cushing Disease.

Hamrahian AH, Yuen KC, Hoffman AR; AACE Neuroendocrine And Pituitary Scientific Committee.

Endocr Pract. 2014 Jul;20(7):746-57. doi: 10.4158/EP14147.RA. Review.

PMID:
25057099
33.

Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiency.

Yuen KC, Roberts CT Jr, Frystyk J, Rooney WD, Pollaro JR, Klopfenstein BJ, Purnell JQ.

J Clin Endocrinol Metab. 2014 Oct;99(10):E1862-9. doi: 10.1210/jc.2014-1532. Epub 2014 Jul 11.

34.

Development of spatial release from masking in mandarin-speaking children with normal hearing.

Yuen KC, Yuan M.

J Speech Lang Hear Res. 2014 Oct;57(5):2005-23. doi: 10.1044/2014_JSLHR-H-13-0060.

PMID:
24950448
35.

Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis.

Tritos NA, Johannsson G, Korbonits M, Miller KK, Feldt-Rasmussen U, Yuen KC, King D, Mattsson AF, Jonsson PJ, Koltowska-Haggstrom M, Klibanski A, Biller BM.

J Clin Endocrinol Metab. 2014 Jun;99(6):2018-29. doi: 10.1210/jc.2014-1013. Epub 2014 Apr 2.

PMID:
24694339
36.

Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study.

Kelly DF, Chaloner C, Evans D, Mathews A, Cohan P, Wang C, Swerdloff R, Sim MS, Lee J, Wright MJ, Kernan C, Barkhoudarian G, Yuen KC, Guskiewicz K.

J Neurotrauma. 2014 Jul 1;31(13):1161-71. doi: 10.1089/neu.2013.3212. Epub 2014 May 8.

37.

Primary treatment regimen and diabetes insipidus as predictors of health outcomes in adults with childhood-onset craniopharyngioma.

Yuen KC, Kołtowska-Häggström M, Cook DM, Fox JL, Jönsson PJ, Geffner ME, Abs R.

J Clin Endocrinol Metab. 2014 Apr;99(4):1227-35. doi: 10.1210/jc.2013-3631. Epub 2014 Jan 29.

PMID:
24476077
38.
39.

Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction.

Yuen KC, Koltowska-Häggström M, Cook DM, Fox JL, Jönsson PJ, Geffner ME, Abs R.

Eur J Endocrinol. 2013 Sep 17;169(4):511-9. doi: 10.1530/EJE-13-0280. Print 2013 Oct.

PMID:
23904277
40.

A long-acting human growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adults.

Yuen KC, Conway GS, Popovic V, Merriam GR, Bailey T, Hamrahian AH, Biller BM, Kipnes M, Moore JA, Humphriss E, Bright GM, Cleland JL.

J Clin Endocrinol Metab. 2013 Jun;98(6):2595-603. doi: 10.1210/jc.2013-1437. Epub 2013 Apr 12.

41.

Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency.

Garcia JM, Swerdloff R, Wang C, Kyle M, Kipnes M, Biller BM, Cook D, Yuen KC, Bonert V, Dobs A, Molitch ME, Merriam GR.

J Clin Endocrinol Metab. 2013 Jun;98(6):2422-9. doi: 10.1210/jc.2013-1157. Epub 2013 Apr 4.

42.

Influence of glucocorticoids and growth hormone on insulin sensitivity in humans.

Yuen KC, Chong LE, Riddle MC.

Diabet Med. 2013 Jun;30(6):651-63. doi: 10.1111/dme.12184. Review.

PMID:
23510125
43.

Adrenal insufficiency in pregnancy: challenging issues in diagnosis and management.

Yuen KC, Chong LE, Koch CA.

Endocrine. 2013 Oct;44(2):283-92. doi: 10.1007/s12020-013-9893-2. Epub 2013 Feb 2. Review.

PMID:
23377701
44.

Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults.

Yuen KC, Biller BM, Katznelson L, Rhoads SA, Gurel MH, Chu O, Corazzini V, Spiller K, Gordon MB, Salvatori R, Cook DM.

Pituitary. 2013 Jun;16(2):220-30. doi: 10.1007/s11102-012-0407-7.

PMID:
22806554
45.

Reevaluating goals of insulin therapy: perspectives from large clinical trials.

Riddle MC, Yuen KC.

Endocrinol Metab Clin North Am. 2012 Mar;41(1):41-56. doi: 10.1016/j.ecl.2012.03.003. Epub 2012 Apr 5. Review.

PMID:
22575406
46.

Glucagon stimulation testing in assessing for adult growth hormone deficiency: current status and future perspectives.

Yuen KC.

ISRN Endocrinol. 2011;2011:608056. doi: 10.5402/2011/608056. Epub 2011 Aug 11.

48.

Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®.

Yuen KC, Amin R.

Patient Prefer Adherence. 2011 Mar 10;5:117-24. doi: 10.2147/PPA.S10985.

49.

Hearing impairment and depressive symptoms in an older chinese population.

Lee AT, Tong MC, Yuen KC, Tang PS, Vanhasselt CA.

J Otolaryngol Head Neck Surg. 2010 Oct;39(5):498-503.

PMID:
20828511
50.

Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes.

Castle JR, Engle JM, El Youssef J, Massoud RG, Yuen KC, Kagan R, Ward WK.

Diabetes Care. 2010 Jun;33(6):1282-7. doi: 10.2337/dc09-2254. Epub 2010 Mar 23.

Supplemental Content

Support Center